Simple Summary Imaging based on positron emission tomography (PET) is a crucial part of up-to-date cancer care. For this purpose, PET employs and marks target structures at the cellular surface. Recently, C-X-C Motif Chemokine Receptor 4 (CXCR4) and Fibroblast Activation Protein Alpha (FAP) emerged as clinically relevant PET targets. However, it is unclear whether high levels of CXCR4 and FAP represent distinct cancer states—especially in solid tumors. Therefore, we established a machine learning model based on 9242 samples from 29 different cancer entities. Our analysis revealed that—in most solid tumors—high levels of CXCR4 were associated with immune cells infiltrating these tumors. Instead, FAP-positive tumors were characteri...
Solid tumors can be primarily resistant or could become resistant to therapy, due to the protective ...
The G protein-coupled protein receptor C-X-C chemokine receptor 4 (CXCR4) is an attractive target fo...
CXCR4, the C-X-C chemokine receptor 4, has been gaining interest as a therapeutic target since its o...
Simple Summary Imaging based on positron emission tomography (PET) is a crucial part of u...
The C-X-C chemokine receptor 4 (CXCR4) is G protein-coupled receptor that upon binding to its cognat...
Simple Summary Beyond its pre-eminent role in the context of tumor cell growth as well as...
Background C-X-C motif chemokine receptor 4 (CXCR4) is overexpressed in various solid cancers and c...
CXCR4 is a G-protein-coupled receptor that mediates recruitment of blood cells toward its ligand SDF...
Given its pre-eminent role in the context of tumor cell growth as well as metastasis, the C-X-C moti...
Purpose Chemokine CXCL12 and its receptor CXCR4 are constitutively overexpressed in human cancers. T...
Despite histological evidence in various solid tumor entities, available experience with CXCR4-direc...
Background: In colorectal cancer (CRC), the consensus molecular subtype 4 (CMS4) is associated with ...
We aimed to elucidate the diagnostic potential of the C-X-C motif chemokine receptor 4 (CXCR4)-direc...
Over the last decades many molecules and key pathways in cancer were identified, which facilitated a...
PURPOSE: CXCR4 (over)expression is found in multiple human cancer types, while expression is low or ...
Solid tumors can be primarily resistant or could become resistant to therapy, due to the protective ...
The G protein-coupled protein receptor C-X-C chemokine receptor 4 (CXCR4) is an attractive target fo...
CXCR4, the C-X-C chemokine receptor 4, has been gaining interest as a therapeutic target since its o...
Simple Summary Imaging based on positron emission tomography (PET) is a crucial part of u...
The C-X-C chemokine receptor 4 (CXCR4) is G protein-coupled receptor that upon binding to its cognat...
Simple Summary Beyond its pre-eminent role in the context of tumor cell growth as well as...
Background C-X-C motif chemokine receptor 4 (CXCR4) is overexpressed in various solid cancers and c...
CXCR4 is a G-protein-coupled receptor that mediates recruitment of blood cells toward its ligand SDF...
Given its pre-eminent role in the context of tumor cell growth as well as metastasis, the C-X-C moti...
Purpose Chemokine CXCL12 and its receptor CXCR4 are constitutively overexpressed in human cancers. T...
Despite histological evidence in various solid tumor entities, available experience with CXCR4-direc...
Background: In colorectal cancer (CRC), the consensus molecular subtype 4 (CMS4) is associated with ...
We aimed to elucidate the diagnostic potential of the C-X-C motif chemokine receptor 4 (CXCR4)-direc...
Over the last decades many molecules and key pathways in cancer were identified, which facilitated a...
PURPOSE: CXCR4 (over)expression is found in multiple human cancer types, while expression is low or ...
Solid tumors can be primarily resistant or could become resistant to therapy, due to the protective ...
The G protein-coupled protein receptor C-X-C chemokine receptor 4 (CXCR4) is an attractive target fo...
CXCR4, the C-X-C chemokine receptor 4, has been gaining interest as a therapeutic target since its o...